Quinapril

BreastfeedingPediatric
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Alcohol, Aldesleukin, Allopurinol, Alpha blockers, Alprostadil, Amifostine, Amiloride, Angiotensin II receptor antagonists, Antacids, Antidiabetics, Antihypertensives, Antipsychotics, Anxiolytics and hypnotics, Aprotinin, Azathioprine, Baclofen, Beta blockers, Calcium channel blockers, Chlortetracycline, Ciprofloxacin, Clonidine, Corticosteroids, Cyclosporine, Demeclocycline, Diazoxide, Diuretics, Doxycycline, Eplerenone, Estrogens, Everolimus, Gemifloxacin, General anesthetics, Gold & Gold Compounds, Heparins, Hydralazine, Insulin, Levodopa, Lithium, Lymecycline, MAO inhibitors, Metformin, Methyldopa, Methylphenidate, Minocycline, Minoxidil, Moxifloxacin, Moxisylyte, Moxonidine, Nitrates, Nitroprusside, NSAIDs, Ofloxacin, Oxytetracycline, Pentoxifylline, Phosphodiesterase 5 inhibitors, Potassium salts, Prostacyclin analogues, Quinine, Quinolones, Rituximab, Salicylates, Sirolimus, Spironolactone, Sulfonylureas, Temsirolimus, Tetracycline, Tetracyclines, Tigecycline, Tizanidine, Tolvaptan, Triamterene, Trimethoprim

PREGNANCY CATEGORY: D
category C in first trimester; category D in second and third trimesters

Contra-indicated in patients with a history of angioedema related to previous treatment with an ACE inhibitor.

FETAL TOXICITY

See full prescribing information for complete boxed warning.

Our database has 35 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
HAIR
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
RESPIRATORY
RENAL
HEMATOLOGIC
OCULAR
OTHER


Page last updated 10/10/2017

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric